Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
KITE

Kite Pharma

$178.61

-0.53 (-0.30%)

, GILD

Gilead

$82.36

0.07 (0.09%)

13:12
09/18/17
09/18
13:12
09/18/17
13:12
Recommendations
Kite Pharma, Gilead analyst commentary at Citi »

Citi does not expect…

KITE

Kite Pharma

$178.61

-0.53 (-0.30%)

GILD

Gilead

$82.36

0.07 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 12

    Feb

Over a week ago
GILD

Gilead

$83.75

0.04 (0.05%)

, KITE

Kite Pharma

$178.05

0.06 (0.03%)

11:40
09/05/17
09/05
11:40
09/05/17
11:40
Recommendations
Gilead, Kite Pharma, Cellectis, Juno Therapeutics analyst commentary at Credit Suisse »

No read through to…

GILD

Gilead

$83.75

0.04 (0.05%)

KITE

Kite Pharma

$178.05

0.06 (0.03%)

CLLS

Cellectis

$32.18

3.42 (11.89%)

JUNO

Juno Therapeutics

$41.92

0.65 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 08

    Sep

  • 11

    Sep

  • 26

    Sep

  • 29

    Nov

  • 12

    Feb

GILD

Gilead

$83.75

0.04 (0.05%)

, BLUE

bluebird bio

$130.85

6 (4.81%)

08:59
09/05/17
09/05
08:59
09/05/17
08:59
Hot Stocks
Gilead, bluebird bio slip after Cellectis trials halted after patient death »

Shares of Cellectis…

GILD

Gilead

$83.75

0.04 (0.05%)

BLUE

bluebird bio

$130.85

6 (4.81%)

KITE

Kite Pharma

$178.05

0.06 (0.03%)

CLLS

Cellectis

$32.18

3.42 (11.89%)

JUNO

Juno Therapeutics

$41.92

0.65 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 08

    Sep

  • 11

    Sep

  • 26

    Sep

  • 27

    Sep

  • 29

    Nov

  • 12

    Feb

AAPL

Apple

$164.05

0.05 (0.03%)

, GE

General Electric

$25.14

0.59 (2.40%)

08:55
09/05/17
09/05
08:55
09/05/17
08:55
Options
Notable open interest changes for September 5th »

Friday's total…

AAPL

Apple

$164.05

0.05 (0.03%)

GE

General Electric

$25.14

0.59 (2.40%)

KITE

Kite Pharma

$178.05

0.06 (0.03%)

MU

Micron

$32.60

0.63 (1.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 06

    Sep

  • 08

    Sep

  • 11

    Sep

  • 26

    Sep

  • 02

    Oct

  • 29

    Nov

CYRX

Cryoport

$7.89

0.21 (2.73%)

, KITE

Kite Pharma

$178.05

0.06 (0.03%)

08:34
09/05/17
09/05
08:34
09/05/17
08:34
Hot Stocks
Cryoport selected to support potential launch of Kite Pharma's axi-cel »

Cryoport (CRYX) announced…

CYRX

Cryoport

$7.89

0.21 (2.73%)

KITE

Kite Pharma

$178.05

0.06 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 07

    Sep

  • 08

    Sep

  • 08

    Sep

  • 09

    Sep

  • 11

    Sep

  • 27

    Sep

  • 28

    Sep

  • 29

    Nov

JUNO

Juno Therapeutics

$40.29

-3.52 (-8.03%)

, KITE

Kite Pharma

$177.90

-0.05 (-0.03%)

10:35
08/31/17
08/31
10:35
08/31/17
10:35
Downgrade
Juno Therapeutics, Kite Pharma, Gilead rating change at Standpoint Research »

Standpoint downgrades…

JUNO

Juno Therapeutics

$40.29

-3.52 (-8.03%)

KITE

Kite Pharma

$177.90

-0.05 (-0.03%)

GILD

Gilead

$81.23

5.49 (7.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Sep

  • 11

    Sep

  • 29

    Nov

  • 12

    Feb

JUNO

Juno Therapeutics

$40.29

-3.52 (-8.03%)

, GILD

Gilead

$81.23

5.49 (7.25%)

09:11
08/31/17
08/31
09:11
08/31/17
09:11
Recommendations
Juno Therapeutics, Gilead, Novartis, Kite Pharma, bluebird bio analyst commentary at Morgan Stanley »

Gilead response to…

JUNO

Juno Therapeutics

$40.29

-3.52 (-8.03%)

GILD

Gilead

$81.23

5.49 (7.25%)

NVS

Novartis

KITE

Kite Pharma

$177.90

-0.05 (-0.03%)

BLUE

bluebird bio

$112.50

10.1 (9.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 08

    Sep

  • 08

    Sep

  • 11

    Sep

  • 29

    Nov

  • 12

    Feb

  • 17

    May

KITE

Kite Pharma

$177.95

-0.1 (-0.06%)

15:45
08/30/17
08/30
15:45
08/30/17
15:45
Options
Kite Pharma call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Sep

  • 29

    Nov

NVS

Novartis

$82.75

-0.87 (-1.04%)

, GILD

Gilead

$75.74

1.05 (1.41%)

15:41
08/30/17
08/30
15:41
08/30/17
15:41
Hot Stocks
Novartis receives first ever CAR-T gene therapy approval in U.S. »

On Wednesday, the Food…

NVS

Novartis

$82.75

-0.87 (-1.04%)

GILD

Gilead

$75.74

1.05 (1.41%)

KITE

Kite Pharma

$177.95

-0.1 (-0.06%)

BLUE

bluebird bio

$102.40

-3.9 (-3.67%)

JUNO

Juno Therapeutics

$43.81

7.33 (20.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 08

    Sep

  • 08

    Sep

  • 11

    Sep

  • 29

    Nov

  • 12

    Feb

  • 17

    May

CYRX

Cryoport

$6.54

-0.09 (-1.36%)

, GILD

Gilead

$75.74

1.05 (1.41%)

14:41
08/30/17
08/30
14:41
08/30/17
14:41
Recommendations
Cryoport, Gilead, Kite Pharma analyst commentary at Needham »

Cryoport price target…

CYRX

Cryoport

$6.54

-0.09 (-1.36%)

GILD

Gilead

$75.74

1.05 (1.41%)

KITE

Kite Pharma

$177.95

-0.1 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 08

    Sep

  • 08

    Sep

  • 09

    Sep

  • 11

    Sep

  • 11

    Sep

  • 27

    Sep

  • 28

    Sep

  • 29

    Nov

  • 12

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.